Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Walking meditation trial aims to strengthen resilience in neurodegenerative disease patients

NCT ID NCT07285954

Symptom relief Sponsor: University of Illinois at Urbana-Champaign Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a walking meditation program called iWalk for adults with neurodegenerative diseases like multiple sclerosis. The goal is to see if it's feasible and helps improve resilience, stress regulation, and thinking skills. Researchers will enroll 90 participants and measure outcomes like resilience scales and cognitive tests.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
walking meditation program (iWalk)
What this could lead to
If it works, this could offer a simple, drug-free way to help people with neurodegenerative diseases feel more resilient and manage stress better.
What could go wrong
This is a small, early feasibility study with only 90 participants, so results may not apply widely. The intervention is behavioral, so benefits may be modest or hard to measure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Dec 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 110 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. 18 years or older, 2. clinical diagnosis of a neurodegenerative disease such as multiple sclerosis, Alzheimer's disease, Parkinson's disease, stroke, etc., 3. have not practiced meditation regularly (e.g., 10 mins per day) and have never attended any meditation classes or community programs, 4. never received meditation training via coaching/certification/life coaching, 5. have internet access, 6. with no severe cognitive impairment, i.e., have a score of ≥ 21 on Modified Telephonic Interview for Cognitive Status (TICS-M), 7. be able to walk with or without an assistive device (Patient determined Disease Steps score ranged from 0-6), 8. are willing to be randomized to an intervention or a control group, 9. are willing to wear Fitbit (a wrist smart watch) for eight weeks, 10. are individuals who are right-handed according to the Edinburgh Handedness Questionnaire, 11. are willing to participate in all assessments, including in-person testing using electroencephalography (EEG) and cognitive tests, online survey/questionnaires, and online interviews or focus group discussions, 12. are willing to wear a Hexoskin t-shirt, which is a heart rate variability monitor, while doing the assessments in person. Exclusion Criteria: Participants who cannot speak, read, write, or listen in English.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adults are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Alzheimer disease Emotional Regulation multiple sclerosis neurodegenerative disease Parkinson disease stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adults EEG Mindfulness Neurodegenerative disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Illinois Urbana-Champaign

    RECRUITING

    Urbana, Illinois, 61801, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.